Abstract
Background and purpose
Complementary and alternative medicine (CAM) is of high relevance in oncology. Only a minority of professionals feel competent in CAM. Our aim was to provide a strategy for establishing evidence-based counseling on CAM in oncology in the German health system.
Methods
We performed a systematic search of the literature on patient counseling concerning CAM. Of 811 articles identified in this search 51 met our inclusion criteria. Data from these articles were analyzed and adapted to the needs of German patients by a group of experts of the DEGRO (“Deutschen Gesellschaft für Radioonkologie”) and the German Cancer Society. In the next step a strategy about how to integrate evidence-based counseling on CAM at cancer centers and oncological institutions was developed.
Results
First, evidence-based recommendations on CAM counseling were derived. The core of our strategy combines two levels of information provision: level 1 will be oncologists, radiotherapists and other specialists and level 2 oncological CAM experts. The latter group will serve as trainers and backup for complicated or advanced questions and for individual counseling of patients with complex needs. Professionals in level 1 will be offered special training.
Conclusion
Evidence-based counseling on CAM is not only possible but also mandatory in order to meet patient information needs. Our proposal would allow for integrated counseling available at all oncological institutions and guarantee a high quality. Furthermore, provision of information on two different levels allows the effective use of resources (manpower and financing).
Zusammenfassung
Hintergrund
Komplementäre und alternative Medizin (KAM) hat eine hohe Bedeutung in der Onkologie. Nur eine Minderheit der Onkologen fühlt sich kompetent bei KAM. Unser Ziel war es, eine Strategie zu entwickeln, wie innerhalb des deutschen Gesundheitssystems evidenzbasierte Beratungen zu KAM aufgebaut werden können.
Methoden
In einer systematischen Literaturrecherche zum Thema Beratung zu KAM wurden 811 Artikel gefunden, von denen 51 inhaltlich dem Thema unserer Arbeit entsprachen. Aus ihnen wurde von einer Expertengruppe der Deutschen Gesellschaft für Radioonkologie und der Deutschen Krebsgesellschaft eine Strategie entwickelt, wie evidenzbasierte Beratung zu KAM in Tumorzentren und anderen onkologischen Institutionen integriert werden kann.
Ergebnisse
Als erstes wurden evidenzbasierte Empfehlungen zur KAM-Beratung erarbeitet. Der Kern der Strategie besteht in 2 Stufen der Informationsvermittlung. Auf Stufe 1 befinden sich Onkologen, Strahlentherapeuten und andere Fachärzte, Stufe 2 bilden Fachärzte mit onkologischem Hintergrund und Expertise in KAM. Diese stehen sowohl als Ausbilder aber auch als Hintergrund für komplizierte und fortgeschrittene Fragen und für die individuelle Beratung von Patienten mit besonderen Bedürfnissen zur Verfügung. Fachärzte erhalten ein spezielles Training.
Schlussfolgerungen
Evidenzbasierte Beratung zu KAM ist möglich und notwendig, um den Informationsbedarf von Patienten zu befriedigen. Unser Vorschlag ermöglicht es, diese Beratungen in allen onkologischen Institutionen zu integrieren und eine hohe Qualität zu garantieren. Durch das Angebot der Informationen auf 2 unterschiedlichen Stufen werden menschliche und finanzielle Ressourcen gespart.
References
Becker-Schiebe M, Mengs U, Schaefer M et al (2011) Topical use of a silymarin-based preparation to prevent radiodermatitis; results of a prospective study in breast cancer patients. Strahlenther Onkol 187(8):485–491
Blank E, Willich N, Fietkau R et al (2012) Evaluation of time, attendance of medical staff, and resources during radiotherapy for breast cancer patients; the DEGRO-QUIRO trial. Strahlenther Onkol 188(2):113–119
Broom A, Tovey P (2008) The role of the internet in cancer patients’ engagement with complementary and alternative treatments. Health (London) 12:139–155
Dennert G, Wolf G (2012) Ressourcenorientierte Beratung von Patientinnen und Patienten zur Komplementäronkologie. Ärztliche Psychother Psychosomatische Med 175–180
Eder-Czembirek C, Erovic BM, Czembirek C et al (2010) Betulinic acid a radiosensitizer in head and neck squamous cell carcinoma cell lines. Strahlenther Onkol 186(3):143–148
Eng J, Ramsum D, Verhoef M et al (2003) A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer. Integr Cancer Ther 2:212–216
Ernst E, Resch KL, Mills S et al (1995) Complementary medicine—a definition. Br J Gen Pract 45:506
Eschiti VS (2007) Lesson from comparison of CAM use by women with female-specific cancers to others: it‘s time to focus on interaction risks with CAM therapies. Integr Cancer Ther 6:313–344
Frenkel M, Ben-Arye E, Cohen L (2010) Communication in cancer care: discussing complementary and alternative medicine. Integr Cancer Ther 9:177–185
Geinitz H, Marten-Mittag B, Schäfer C et al (2012) Patient satisfaction during radiation therapy. Correlates and patient suggestions. Strahlenther Onkol 188(6):492–498
Hann D, Allen S, Ciambrone D, Shah A (2006) Use of complementary therapies during chemotherapy: Influence of patients’ satisfaction with treatment decision making and the treating oncologist. Integr Cancer Ther 5:224–231
Hübner J, Dennert G, Münstedt K (2012) Beratungsangebote zu komplementären und alternative Methoden in der Onkologie. Forum 27:136–139
Maskarinec G, Gotay CC, Tatsumura Y et al (2001) Perceived cancer causes: use of complementary and alternative therapy. Cancer Pract 9:183–190
Micke O, Bruns F, Glatzel M et al (2009) Predictive factors for the use of complementary and alternative medicine (CAM) in radiation oncology. Eur J Integr Med 1:22–30
Molassiotis A, Fernadez-Ortega P, Pud D et al (2005) Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 16:655–663
Münstedt K, Harren H, Georgi R von, Hackethal A (2011) Conplementary and alternative medicine: comparison of current knowledge, attitudes and interest among German medical students and doctors. Evid Based Complement Alternat Med. doi: 10.1093/ecam/nen079
Robinson A, McGrail MR (2004) Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies. Complement Ther Med 12:90–98
Saxe GA, Madlensky L, Kealey S et al (2008) Disclosure to physicians of CAM use by breast cancer patients: findings from the Women’s Healthy Eating and Living Study. Integr Cancer Ther 7:122–129
Schofield P, Diggens J, Charleson C et al (2010) Effectively discussing complementary and alternative medicine in a conventional oncology setting: communication recommendations for clinicians. Patient Educ Couns 79:143–151
Shelley BM, Sussman AL, Williams RL et al (2009) They don’t ask me so I don’t tell them: patient–clinician communication about traditional, complementary, and alternative medicine. Ann Fam Med 7:139–147
Singh H, Maskarinec G, Shumay DM (2005) Understanding the motivation for conventional and complementary/alternative medicine use among men with prostate cancer. Integr Cancer Ther 4:187–194
Snyder JD for the American College of Physicians Ethics, Professionalism, and Human Rights Committee (2012) American College of Physicians Ethics Manual, 6. Edn. http://www.acponline.org/running_practice/ethics/manual/manual6th.htm Accessed: 17 June 2013
Verhoef MJ (2009) Complementary therapies for cancer patients: assessing information use and needs. Chronic Dis Can 29:80–85
Conflict of interest
On behalf of all authors, the corresponding author states that there are no conflicts of interest.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Hübner, J., Muenstedt, K., Muecke, R. et al. Counseling cancer patients on complementary and alternative medicine. Strahlenther Onkol 189, 613–617 (2013). https://doi.org/10.1007/s00066-013-0392-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00066-013-0392-4